Cardurion

Biotechnology · Burlington, MA · Founded 2017 · Privately Held (backing)

Developer of cardiovascular therapeutics intended to treat cardiovascular diseases. Cardurion is based in Burlington, MA and was founded in 2017. Its last known valuation is $760 million. It has raised $622 million across 1 recorded round; the latest was a $260 million Series B in Jul 2024.

Last price · $/share
—
Implied valuation
$760.0M
Total raised
$621.8M
Last round
Later Stage VC (Series B)
Jul 2024
How much has Cardurion raised?
$621.8Macross 1 recorded rounds · Jul 2024 – Jul 2024

Most recently, Cardurion raised $260.0M in its Later Stage VC (Series B) (Jul 2024).

Free account
More of Cardurion with a free account
  • ·The complete investor list: 16 names
  • ·Watch Cardurion: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Cardurion round by round

1 rounds
Jul 2024Later Stage VC (Series B)$260.0M▮
+ 1 more investors · free account

How much has Cardurion raised?

Cardurion has raised $622 million in total; 1 of its rounds is on record. The largest on record was a $260 million Series B in Jul 2024.

Cardurion investors

16 investors are on record for Cardurion, including Fidelity Management & Research Company, GV, New Enterprise Associates and Blue Owl Capital. By type, the record holds 6 venture capital firms, 2 hedge funds and 2 private equity firms. The Series B in Jul 2024 drew 11 investors.

For fundraisers
Raising for a company like Cardurion?

16 investors have backed Cardurion — start your target list with the firms already writing checks in biotechnology.

See all 16 investors →

Frequently asked about Cardurion

How much has Cardurion raised?
Cardurion has raised $621.8M in total across 1 recorded funding rounds.
When was Cardurion's last funding round?
Cardurion's most recent recorded round was Later Stage VC (Series B) in Jul 2024, raising $260.0M.